Efficacy of trastuzumab-based therapy after disease progression on lapatinib based therapy in heavily pretreated HER2-positive metastatic breast cancer patients.

Basit Öğe Kaydı
dc.contributor.authorUncu, Dogan
dc.contributor.authorBayoglu, Ibrahim Vedat
dc.contributor.authorArslan, Ulku Yalcintas
dc.contributor.authorKucukoner, Mehmet
dc.contributor.authorArtac, Mehmet
dc.contributor.authorKoca, Dogan
dc.contributor.authorOguz, Arzu
dc.date.accessioned2020-03-26T18:50:25Z
dc.date.available2020-03-26T18:50:25Z
dc.date.issued2014
dc.departmentSelçuk Üniversitesien_US
dc.description50th Annual Meeting of the American-Society-of-Clinical-Oncology -- MAY 30-JUN 03, 2014 -- Chicago, ILen_US
dc.description.abstract[Abstract not Available]en_US
dc.description.sponsorshipAmer Soc Clin Oncolen_US
dc.identifier.doi10.1200/jco.2014.32.15_suppl.e11586en_US
dc.identifier.issn0732-183Xen_US
dc.identifier.issn1527-7755en_US
dc.identifier.issue15en_US
dc.identifier.urihttps://dx.doi.org/10.1200/jco.2014.32.15_suppl.e11586
dc.identifier.urihttps://hdl.handle.net/20.500.12395/30808
dc.identifier.volume32en_US
dc.identifier.wosWOS:000358613200080en_US
dc.identifier.wosqualityQ1en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.language.isoenen_US
dc.publisherAMER SOC CLINICAL ONCOLOGYen_US
dc.relation.ispartofJOURNAL OF CLINICAL ONCOLOGYen_US
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.selcuk20240510_oaigen_US
dc.titleEfficacy of trastuzumab-based therapy after disease progression on lapatinib based therapy in heavily pretreated HER2-positive metastatic breast cancer patients.en_US
dc.typeConference Objecten_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu